All In Biotech

Drug Trial Radar · NCT01918488

Increased Activity of a Renal Salt Transporter (ENaC) in Diabetic Kidney Disease

Increased Activity of the Epithelial Sodium Channel (ENaC) in Diabetic Nephropathy

Last checked: Nov 19, 2026Latest source record: Oct 16, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

80

Planned (sponsor's estimate)

Start

Oct 2013

Primary completion

Dec 2014

Sponsor

Lead sponsor
University of Southern DenmarkAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Odense University Hospital; Region of Southern Denmark; The Ministry of Science, Technology and Innovation, Denmark; Danish Heart Foundation
First posted
Aug 7, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Basic science
Who can join
All sexes, from 18 years, up to 90 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to determine whether a diuretic drug called amiloride is capable of increasing renal salt excretion and thereby decrease blood pressure in diabetic patients with kidney disease. Our hypothesis states that amiloride is capable of reducing blood pressure in these patients and thus decrease the cardiovascular risk associated with diabetic kidney disease.

Conditions

  • Diabetic Nephropathies
  • Hypertension

Interventions

  • Standardized salt dietDietary supplement

    200 mmol NaCl per day given as three meals daily for 4 consecutive days.

  • AmilorideDrug

    Amiloride tablet 20 mg two times daily (morning and afternoon) for two consecutive days.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 24-hour urinary sodium excretion induced by amilorideTime frame: Change from baseline urinary sodium excretion at 24 hours after amiloride administration

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Cardiovascular and Renal Research

    Odense, Denmark

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.